Snehal Patel

Insider Reports History

Reporting-owner location: Stafford, TX
Latest reporting-owner signature: /s/ Snehal Patel
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Snehal Patel

Form 4 holding CEO and CFO, Director, 10%+ Owner

Greenwich LifeSciences, Inc.

Security class: Common Stock
Shares / value: 5,611,402
Estimated value: $73,509,366
Report date: 29 Jul 2026
Price: $13.10
Ownership: Direct

Form 4 holding CEO and CFO, Director, 10%+ Owner

Greenwich LifeSciences, Inc.

Security class: Stock Options
Shares / value: 2,347,462
Estimated value
Report date: 13 Nov 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Snehal Patel

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 28 Jul 2026
Transactions: 2
Transaction value: +$29,555
Accepted by SEC: 30 Jul 2026, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 27 Jul 2026
Transactions: 1
Transaction value: +$20,430
Accepted by SEC: 29 Jul 2026, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 23 Jul 2026
Transactions: 2
Transaction value: +$47,018
Accepted by SEC: 27 Jul 2026, 06:15
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 13 Jan 2026
Transactions: 1
Transaction value: +$53,694
Accepted by SEC: 15 Jan 2026, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 12 Jan 2026
Transactions: 1
Transaction value: +$79,866
Accepted by SEC: 14 Jan 2026, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 31 Dec 2025
Transactions: 1
Transaction value: +$91,848
Accepted by SEC: 05 Jan 2026, 06:06
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 30 Dec 2025
Transactions: 1
Transaction value: +$63,017
Accepted by SEC: 02 Jan 2026, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 18 Dec 2025
Transactions: 1
Transaction value: +$51,742
Accepted by SEC: 19 Dec 2025, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 25 Nov 2025
Transactions: 1
Transaction value: +$38,502
Accepted by SEC: 28 Nov 2025, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 13 Nov 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 17 Nov 2025, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 07 Nov 2025
Transactions: 1
Transaction value: +$89,358
Accepted by SEC: 12 Nov 2025, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 31 Oct 2025
Transactions: 1
Transaction value: +$21,298
Accepted by SEC: 04 Nov 2025, 06:16
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 25 Apr 2025
Transactions: 1
Transaction value: +$35,568
Accepted by SEC: 29 Apr 2025, 06:14
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 17 Apr 2025
Transactions: 1
Transaction value: +$48,492
Accepted by SEC: 22 Apr 2025, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 07 Apr 2025
Transactions: 1
Transaction value: +$32,760
Accepted by SEC: 08 Apr 2025, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 04 Apr 2025
Transactions: 1
Transaction value: +$48,015
Accepted by SEC: 07 Apr 2025, 07:50
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 10 Jan 2025
Transactions: 1
Transaction value: +$31,275
Accepted by SEC: 13 Jan 2025, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 06 Jan 2025
Transactions: 2
Transaction value: +$39,391
Accepted by SEC: 08 Jan 2025, 06:10
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 03 Jan 2025
Transactions: 1
Transaction value: +$44,030
Accepted by SEC: 07 Jan 2025, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 02 Jan 2025
Transactions: 1
Transaction value: +$23,940
Accepted by SEC: 06 Jan 2025, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 31 Dec 2024
Transactions: 1
Transaction value: +$27,264
Accepted by SEC: 03 Jan 2025, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 30 Dec 2024
Transactions: 1
Transaction value: +$35,584
Accepted by SEC: 02 Jan 2025, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 24 Dec 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 27 Dec 2024, 16:19
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 26 Sep 2024
Transactions: 1
Transaction value: +$21,945
Accepted by SEC: 30 Sep 2024, 06:04
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 06 Aug 2024
Transactions: 1
Transaction value: +$27,620
Accepted by SEC: 08 Aug 2024, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 05 Aug 2024
Transactions: 1
Transaction value: +$72,490
Accepted by SEC: 07 Aug 2024, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 23 Jul 2024
Transactions: 1
Transaction value: +$23,835
Accepted by SEC: 24 Jul 2024, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 13 Jun 2024
Transactions: 1
Transaction value: +$2,499,998
Accepted by SEC: 17 Jun 2024, 06:10
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 01 Apr 2024
Transactions: 1
Transaction value: +$57,240
Accepted by SEC: 03 Apr 2024, 06:10
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 22 Mar 2024
Transactions: 1
Transaction value: +$49,950
Accepted by SEC: 26 Mar 2024, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 20 Mar 2024
Transactions: 1
Transaction value: +$26,520
Accepted by SEC: 22 Mar 2024, 06:02
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4/A GLSI

Greenwich LifeSciences, Inc.

Report period: 05 Mar 2024
Transactions: 1
Transaction value: +$43,715
Accepted by SEC: 07 Mar 2024, 09:41
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 05 Mar 2024
Transactions: 1
Transaction value: +$380,945
Accepted by SEC: 07 Mar 2024, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 04 Mar 2024
Transactions: 1
Transaction value: +$53,423
Accepted by SEC: 06 Mar 2024, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 16 Feb 2024
Transactions: 1
Transaction value: +$120,528
Accepted by SEC: 21 Feb 2024, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 15 Feb 2024
Transactions: 1
Transaction value: +$140,589
Accepted by SEC: 20 Feb 2024, 06:04
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 10 Nov 2023
Transactions: 1
Transaction value: +$50,838
Accepted by SEC: 14 Nov 2023, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 03 Nov 2023
Transactions: 1
Transaction value: +$31,885
Accepted by SEC: 07 Nov 2023, 06:15
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 26 Oct 2023
Transactions: 1
Transaction value: +$19,925
Accepted by SEC: 30 Oct 2023, 06:15
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 25 Oct 2023
Transactions: 1
Transaction value: +$19,775
Accepted by SEC: 27 Oct 2023, 06:15
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 10 Oct 2023
Transactions: 1
Transaction value: +$9,070
Accepted by SEC: 12 Oct 2023, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 04 Oct 2023
Transactions: 1
Transaction value: +$17,260
Accepted by SEC: 05 Oct 2023, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 19 Sep 2023
Transactions: 1
Transaction value: +$35,800
Accepted by SEC: 21 Sep 2023, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 11 Sep 2023
Transactions: 1
Transaction value: +$9,480
Accepted by SEC: 13 Sep 2023, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 22 Aug 2023
Transactions: 1
Transaction value: +$9,970
Accepted by SEC: 24 Aug 2023, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 04 Aug 2023
Transactions: 1
Transaction value: +$21,100
Accepted by SEC: 08 Aug 2023, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 21 Jul 2023
Transactions: 1
Transaction value: +$9,200
Accepted by SEC: 25 Jul 2023, 06:15
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 17 May 2023
Transactions: 1
Transaction value: +$11,690
Accepted by SEC: 18 May 2023, 06:01
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 19 Apr 2023
Transactions: 1
Transaction value: +$77,700
Accepted by SEC: 21 Apr 2023, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 18 Apr 2023
Transactions: 1
Transaction value: +$22,240
Accepted by SEC: 20 Apr 2023, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 11 Apr 2023
Transactions: 1
Transaction value: +$62,100
Accepted by SEC: 12 Apr 2023, 06:02
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 10 Mar 2023
Transactions: 1
Transaction value: +$12,120
Accepted by SEC: 13 Mar 2023, 07:15
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 17 Feb 2023
Transactions: 1
Transaction value: +$9,918
Accepted by SEC: 22 Feb 2023, 05:07
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 10 Feb 2023
Transactions: 1
Transaction value: +$18,680
Accepted by SEC: 14 Feb 2023, 05:08
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 27 Jan 2023
Transactions: 1
Transaction value: +$38,700
Accepted by SEC: 31 Jan 2023, 05:15
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 20 Jan 2023
Transactions: 1
Transaction value: +$26,055
Accepted by SEC: 24 Jan 2023, 05:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 06 Jan 2023
Transactions: 1
Transaction value: +$22,770
Accepted by SEC: 10 Jan 2023, 05:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 29 Dec 2022
Transactions: 1
Transaction value: +$60,760
Accepted by SEC: 03 Jan 2023, 05:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 16 Dec 2022
Transactions: 1
Transaction value: +$13,010
Accepted by SEC: 20 Dec 2022, 05:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 09 Dec 2022
Transactions: 1
Transaction value: +$26,220
Accepted by SEC: 13 Dec 2022, 05:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 02 Dec 2022
Transactions: 1
Transaction value: +$13,840
Accepted by SEC: 06 Dec 2022, 05:15
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 02 Nov 2022
Transactions: 1
Transaction value: +$17,580
Accepted by SEC: 04 Nov 2022, 06:15
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 14 Oct 2022
Transactions: 1
Transaction value: +$29,250
Accepted by SEC: 17 Oct 2022, 07:00
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 07 Oct 2022
Transactions: 1
Transaction value: +$19,440
Accepted by SEC: 11 Oct 2022, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 30 Sep 2022
Transactions: 1
Transaction value: +$9,460
Accepted by SEC: 04 Oct 2022, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 29 Sep 2022
Transactions: 1
Transaction value: +$9,230
Accepted by SEC: 03 Oct 2022, 06:15
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 24 Jun 2022
Transactions: 2
Transaction value: +$264,770
Accepted by SEC: 27 Jun 2022, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 22 Jun 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 24 Jun 2022, 08:16
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 16 Jun 2022
Transactions: 1
Transaction value: +$57,040
Accepted by SEC: 17 Jun 2022, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 14 Jun 2022
Transactions: 1
Transaction value: +$94,920
Accepted by SEC: 15 Jun 2022, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 10 Jun 2022
Transactions: 1
Transaction value: +$99,960
Accepted by SEC: 13 Jun 2022, 06:04
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 09 Jun 2022
Transactions: 1
Transaction value: +$49,050
Accepted by SEC: 10 Jun 2022, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 07 Jun 2022
Transactions: 1
Transaction value: +$51,300
Accepted by SEC: 08 Jun 2022, 06:07
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 03 Jun 2022
Transactions: 1
Transaction value: +$77,238
Accepted by SEC: 06 Jun 2022, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 02 Jun 2022
Transactions: 1
Transaction value: +$49,992
Accepted by SEC: 03 Jun 2022, 06:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 21 Apr 2022
Transactions: 1
Transaction value: +$96,540
Accepted by SEC: 22 Apr 2022, 06:04
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 19 Apr 2022
Transactions: 1
Transaction value: +$100,440
Accepted by SEC: 21 Apr 2022, 06:03
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 11 Feb 2022
Transactions: 1
Transaction value: +$108,900
Accepted by SEC: 14 Feb 2022, 05:06
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 04 Feb 2022
Transactions: 1
Transaction value: +$97,950
Accepted by SEC: 08 Feb 2022, 05:02
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 13 Jan 2022
Transactions: 1
Transaction value: +$19,990
Accepted by SEC: 18 Jan 2022, 05:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 03 Jan 2022
Transactions: 1
Transaction value: +$48,831
Accepted by SEC: 04 Jan 2022, 05:05
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

4 GLSI

Greenwich LifeSciences, Inc.

Report period: 14 Dec 2021
Transactions: 1
Transaction value: +$49,992
Accepted by SEC: 16 Dec 2021, 05:08
Role: CEO and CFO, Director, 10%+ Owner
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .